Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Catheter EquipmentCardiovascular Device

PUBLISHER: Grand View Research | PRODUCT CODE: 1375902

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1375902

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Coronary Stents Market Growth & Trends:

The global coronary stents market size is expected to reach USD 12.10 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 3.1% from 2023 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology.

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021.

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period.

Coronary Stents Market Report Highlights:

  • Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions
  • The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.
  • Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market
  • North America dominated the coronary stents market and accounted for the largest revenue share of 32.6% in 2022 and is anticipated to witness the same trend over the foreseeable future.
  • The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.
Show more
Product Code: GVR-1-68038-106-1

Table of Contents

Chapter 1. Methodology & Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary stents Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Coronary Stents Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Coronary stents: Product Estimates & Trend Analysis

  • 4.1. Coronary Stents Market: Key Takeaways
  • 4.2. Coronary Stents Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Bare Metal Stents (BMS)
    • 4.3.1. Bare Metal Stents (BMS) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Drug-Eluting Stents (DES)
    • 4.4.1. Drug-Eluting Stents (DES) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Biodegradable
      • 4.4.1.1.1. Biodegradable market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Non-Biodegradable
      • 4.4.1.2.1. Non-Biodegradable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Bioresorbable Vascular Scaffold
    • 4.5.1. Bioresorbable vascular scaffold market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Coronary Stents Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Coronary Stents Market by Region: Key Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Abbott
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Medtronic
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Boston Scientific Corporation
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Terumo Corporation
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. B Braun Melsungen AG
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Biotronik
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Stentys SA
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. MicroPort Scientific Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. C.R. Bard, Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Cook Medical
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
Show more
Product Code: GVR-1-68038-106-1

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 4 U.S. coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 8 Germany coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 10 France coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 18 Japan coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 19 China coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 20 India coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa coronary stents market, by country, 2018 - 2030 (USD Million)
  • Table 31 South Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait coronary stents market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Coronary stents: Market outlook
  • Fig. 9 Coronary stents: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Coronary stents market driver impact
  • Fig. 15 Coronary stents market restraint impact
  • Fig. 16 Coronary stents market strategic initiatives analysis
  • Fig. 17 Coronary stents market: Product movement analysis
  • Fig. 18 Coronary stents market: Product outlook and key takeaways
  • Fig. 19 Bare metal stents (BMS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Drug-eluting stents (DES) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Non-Biodegradable market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Bioresorbable vascular scaffold market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global coronary stents market: Regional movement analysis
  • Fig. 25 Global coronary stents market: Regional outlook and key takeaways
  • Fig. 26 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!